AMPH CIK: 1297184

Amphastar Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
200
FY22:
249
FY23:
351
FY24:
374
FY25:
356
(positive)
Change from FY21 to FY25
millions USD
FY21:
69.9
FY22:
107
FY23:
197
FY24:
205
FY25:
140
(positive)
Change from FY21 to FY25
millions USD
FY21:
112
FY22:
146
FY23:
240
FY24:
277
FY25:
212
(positive)
Change from FY21 to FY25
millions USD
FY21:
84.1
FY22:
116
FY23:
171
FY24:
190
FY25:
124
(positive)
Change from FY21 to FY25
millions USD
FY21:
62.1
FY22:
91.4
FY23:
138
FY24:
160
FY25:
98.1

All amounts in millions USD Data sources:SEC EDGARTwelve Data